CollPlant Biotechnologies (CLGN) Interest & Investment Income (2017 - 2021)
CollPlant Biotechnologies (CLGN) reported Interest & Investment Income of $189.0 million for Q3 2021, up 1011.76% on a YoY basis from $17.0 million in Q3 2020, and up 154818.03% quarter-over-quarter from $122000.0 in Q2 2021.
CollPlant Biotechnologies (CLGN) Interest & Investment Income (2017 - 2021) Analysis & Trends
CollPlant Biotechnologies has reported Interest & Investment Income for 5 years, with the latest figure at $189.0 million in Q3 2021.
- For the quarter ending Q3 2021, Interest & Investment Income rose 1011.76% year-over-year to $189.0 million; the trailing twelve-month figure through Sep 2021 stood at $189.0 million (up 1011.76% YoY), and the FY2025 full-year result was $380000.0, down 48.51% from the prior year.
- Interest & Investment Income for Q3 2021 stood at $189.0 million, up from $122000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $189.0 million in Q3 2021, with the low at -$112000.0 in Q1 2018.
- Historically, Interest & Investment Income has averaged $17.2 million across 5 years, with a median of $21500.0 in 2020.
- Annual changes were most pronounced in 2019 — Interest & Investment Income jumped 1440.43% — and 2020, when it sank 95.87%.
- CollPlant Biotechnologies' Interest & Investment Income stood at -$81000.0 in 2017, then sank by 30.86% to -$106000.0 in 2018, then jumped by 694.34% to $630000.0 in 2019, then surged by 2598.41% to $17.0 million in 2020, then jumped by 1011.76% to $189.0 million in 2021.
- The last three Interest & Investment Income figures came in at $189.0 million (Q3 2021), $122000.0 (Q2 2021), and $50000.0 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -14.79 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 189.00 Mn |
| Jun 30, 2021 | 122,000.00 |
| Mar 31, 2021 | 50,000.00 |
| Sep 30, 2020 | 17.00 Mn |
| Jun 30, 2020 | 26,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Jun 30, 2019 | 630,000.00 |
| Mar 31, 2019 | -16,000.00 |
| Sep 30, 2018 | -106,000.00 |
| Jun 30, 2018 | -47,000.00 |
| Mar 31, 2018 | -112,000.00 |
| Dec 31, 2017 | -81,000.00 |